Page 9 - Maureen Testoni News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Astroturf Campaign Attacks Discount Drug Program for the Poor An anti–government waste group is helping its Big Pharma funder oppose a discount drug program that doesn’t cost the government a penny. Steve Ruark/AP Images for AIDS Healthcare Foundation Protesters rallied outside pharmaceutical firm AstraZeneca, October 14, 2020, in Wilmington, Delaware, after the company stopped offering drug discounts required by the 340B program. Sludge produces investigative journalism on lobbying and money in politics. The American Prospect  is re-publishing this article. Each year, thou...

Hospitals file lawsuit over drug companies' refusal to give 340B discounts A growing number of drug companies have refused to provide discounts after an HHS decision to cut payments by 30% was upheld on appeal. , Managing Editor Five hospital groups and an organization of hospital pharmacists representing participants in the 340B drug pricing program, have filed a federal lawsuit against the U.S. Department of Health and Human Services over what they call the department's failure to enforce program requirements that require drug companies to provide prescription drug discount...

To embed, copy and paste the code into your website or blog: On Thursday, 10 December 2020, the Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) issued a pre-publication copy of the long-awaited 340B Drug Pricing Program Alternative Dispute Resolution (ADR) Final Rule. 1 The Final Rule was issued more than 10 years after the Affordable Care Act (ACA) amended the 340B statute to require the Secretary of HHS to promulgate regulations establishing and implementing a binding ADR process to resolve certain disputes between covered entities and manu...

UPDATE: Dec. 15, 2020: Twenty-eight states' and the District of Columbia's attorneys general urged HHS to force drugmakers to comply with the 340B drug pricing program rules in a Monday letter. Led by California Attorney General Xavier Becerra, President-elect Joe Biden's pick to lead HHS, the group alleges Eli Lilly, AstraZeneca, Sanofi, Novartis, Merck & Co., United Therapeutics and other pharmas have unlawfully refused to give discounts to covered entities. Dive Brief: Six provider groups including the American Hospital Association on Friday filed a federal lawsuit against HHS, alleging t...

HRSA Publishes Long-Awaited (and Long-Overdue) 340B Program Alternative Dispute Resolution Process Final Rule USA December 11 2020 On Thursday, 10 December 2020, the Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) issued a pre-publication copy of the long-awaited 340B Drug Pricing Program Alternative Dispute Resolution (ADR) Final Rule. 1 The Final Rule was issued more than 10 years after the Affordable Care Act (ACA) amended the 340B statute to require the Secretary of HHS to promulgate regulations establishing and implementing a binding ADR...